Pharma and ESG: the Patient Perspective

Environmental, Social and Governance (ESG) Pharma Report - 2023

“Pharma and ESG: the Patient Perspective”


(currently available languages)

Survey Closes October 10th 2023


A term created by the United Nations Global Compact Office in 2005, ESG is commonly used to denote ‘environmental, social, and governance value drivers in asset management and financial research’.

Since then, the importance of ESG has grown as the financial implications associated with environmental and social damage have become all too apparent for governments, businesses, and institutions. The pharmaceutical industry included.

Most, if not all, pharma companies have developed responses to ESG-related challenges as it affects their inward investment. PatientView’s annual report – ‘Pharma and ESG: the Patient Perspective’ – amplifies the patient voice on this topic.


The emerging dialogue suggests a growing belief that ESG measures are linked to reputation indicators:

For more information or if you would like to order the ESG report, get in contact with us using the form below: